{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:44:16Z","timestamp":1777603456025,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["JP15H04652"],"award-info":[{"award-number":["JP15H04652"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"MEXT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bmc.2019.02.013","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T06:31:16Z","timestamp":1549780276000},"page":"1130-1138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands"],"prefix":"10.1016","volume":"27","author":[{"given":"Maxwell M.","family":"Sakyiamah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9786-2608","authenticated-orcid":false,"given":"Takuya","family":"Kobayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Konno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8348-7544","authenticated-orcid":false,"given":"Wataru","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Tamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.02.013_h0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/382635a0","article-title":"Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF\/SDF-1","volume":"382","author":"Nagasawa","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2019.02.013_h0010","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.8342023","article-title":"Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins","volume":"261","author":"Tashiro","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bmc.2019.02.013_h0015","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/382829a0","article-title":"The lymphocyte chemoattractant SDF-1 is a ligand for LESTR\/fusin and blocks HIV-1 entry","author":"Bleul","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2019.02.013_h0020","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/382833a0","article-title":"The CXC chemokine SDF-1 is the ligand for LESTR\/fusin and prevents infection by T-cell-line-adapted HIV-1","volume":"382","author":"Oberlin","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2019.02.013_h0025","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1006\/dbio.1999.9405","article-title":"Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4","volume":"213","author":"McGrath","year":"1999","journal-title":"Dev Biol"},{"key":"10.1016\/j.bmc.2019.02.013_h0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jneuroim.2008.04.008","article-title":"CXCR4 signaling in the regulation of stem cell migration and development","volume":"198","author":"Miller","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.bmc.2019.02.013_h0035","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2019.02.013_h0040","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.272.5263.872","article-title":"HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor","volume":"272","author":"Feng","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bmc.2019.02.013_h0045","first-page":"3530","article-title":"Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression","volume":"6","author":"Koshiba","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2019.02.013_h0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2019.02.013_h0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-5793(03)00824-X","article-title":"T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer","volume":"550","author":"Tamamura","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2019.02.013_h0060","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.4049\/jimmunol.165.11.6590","article-title":"Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium","volume":"165","author":"Nanki","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2019.02.013_h0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.febslet.2004.05.056","article-title":"Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent","volume":"569","author":"Tamamura","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2019.02.013_h0070","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.186.8.1389","article-title":"A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection","volume":"186","author":"Mutakami","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.bmc.2019.02.013_h0075","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.186.8.1383","article-title":"Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4","volume":"186","author":"Schols","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.bmc.2019.02.013_h0080","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1073\/pnas.0630420100","article-title":"Aduodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity","volume":"100","author":"Ichiyama","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2019.02.013_h0085","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1039\/b306473p","article-title":"Synthesis of potent CXCR4 inhibitors possessing low cytotoxicity and improved biostability based on T140 derivatives","volume":"1","author":"Tamamura","year":"2003","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2019.02.013_h0090","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1039\/b306613b","article-title":"Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists","volume":"1","author":"Tamamura","year":"2003","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2019.02.013_h0095","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/j.1476-5381.2011.01551.x","article-title":"Pharmacological modulation of chemokine receptor function","volume":"165","author":"Scholten","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2019.02.013_h0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1586\/era.11.11","article-title":"Potential of CXCR4 antagonists for the treatment of metastatic lung cancer","volume":"11","author":"Burger","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.bmc.2019.02.013_h0105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1021\/jm049429h","article-title":"Stereoselective synthesis of [L-Arg-L\/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131","volume":"48","author":"Tamamura","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.02.013_h0110","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1021\/jm050009h","article-title":"Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds","volume":"48","author":"Tamamura","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.02.013_h0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-5793(02)03143-5","article-title":"Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4","volume":"527","author":"Hatse","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2019.02.013_b0020","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cmdc.201000548","article-title":"Azamacrocyclic metal complexes as CXCR4 antagonists","volume":"6","author":"Tanaka","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2019.02.013_b0025","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1021\/jm060025u","article-title":"Identification of a new class of low molecular weight antagonists against the chemokine receptor CXCR4 having the dipicolylamine-zinc(II) complex structure","volume":"49","author":"Tamamura","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.02.013_b0030","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bcp.2008.12.014","article-title":"The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil)","volume":"77","author":"De Clercq","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2019.02.013_b0035","unstructured":"Sakyiamah MM, Nomura W, Kobayakawa T, Tamamura H. Development of a NanoBRET-based sensitive screening method for CXCR4 ligands. Bioconjugate Chem. submitted."},{"key":"10.1016\/j.bmc.2019.02.013_h0140","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1021\/acschembio.5b00143","article-title":"A Novel BRET platform for the analysis of protein\u2212protein interactions","volume":"10","author":"Machleidt","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2019.02.013_h0145","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nmeth.3398","article-title":"Application of BRETto monitor ligand binding to GPCRs","volume":"12","author":"Stoddart","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.bmc.2019.02.013_h0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nprot.2006.52","article-title":"Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions","volume":"1","author":"Pfleger","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bmc.2019.02.013_h0155","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1021\/ja807921k","article-title":"Binding optimization through coordination chemistry: CXCR4 chemokine receptor antagonists from ultra-rigid metal complexes","volume":"131","author":"Khan","year":"2009","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2019.02.013_h0160","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1021\/bi0264770","article-title":"Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor","volume":"42","author":"Gerlach","year":"2003","journal-title":"Biochem"},{"key":"10.1016\/j.bmc.2019.02.013_b0050","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1039\/b812029c","article-title":"Structure-activity relationship study of CXCR4 antagonists bearing the cyclic pentapeptide scaffold: identification of the new pharmacophore","volume":"6","author":"Tanaka","year":"2008","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2019.02.013_h0170","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1248\/bpb.19.456","article-title":"Differential contribution of metal complexation and dimerization to the chemotherapeutic potential of bicyclen-Zn (II) complex against human immunodeficiency virus","volume":"19","author":"Inouye","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bmc.2019.02.013_h0175","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/ic9020614","article-title":"Oxovanadium(IV) Cyclam and bicyclam complexes: potential CXCR4 receptor antagonists","volume":"49","author":"Ross","year":"2010","journal-title":"Inorg Chem"},{"key":"10.1016\/j.bmc.2019.02.013_h0180","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1021\/ja0260723","article-title":"Structure and dynamics of metallomacrocycles: recognition of zinc Xylyl-Bicyclam by an HIV coreceptor","volume":"124","author":"Liang","year":"2002","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2019.02.013_h0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3233(08)60534-3","article-title":"Structural aspects of metal liganding to functional groups in proteins","volume":"42","author":"Glusker","year":"1991","journal-title":"Adv Protein Chem"},{"key":"10.1016\/j.bmc.2019.02.013_b0065","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1128\/JVI.73.4.2752-2761.1999","article-title":"Identification of CXCR4 domains that support co-receptor and chemokine receptor functions","volume":"73","author":"Doranz","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2019.02.013_b0070","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1074\/jbc.M309546200","article-title":"Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor","volume":"279","author":"Rosenkilde","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618321837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618321837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:01:23Z","timestamp":1760835683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089618321837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0968089618321837"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.02.013","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}